Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | METTL3 | Q86U44 | 17/20 | 0.55 |
| ▸ | EGFR | P00533 | 3/20 | 0.45 |
| ▸ | SRC | P12931 | 3/20 | 0.45 |
| ▸ | CDK1 | P06493 | 2/20 | 0.45 |
| ▸ | ABL1 | P00519 | 2/20 | 0.45 |
| ▸ | KDR | P35968 | 2/20 | 0.45 |
| ▸ | ABL2 | P42684 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23283550 | 0.74 | METTL3 (0.52) | METTL3EGFRSRCCDK1ABL1 | |
| SCHEMBL23283390 | 0.74 | METTL3 (0.54) | METTL3EGFRSRCCDK1ABL1 | |
| SCHEMBL23283551 | 0.74 | METTL3 (0.57) | METTL3EGFRSRCCDK1ABL1 | |
| SCHEMBL24635165 | 0.72 | METTL3 (1.00) | METTL3 | |
| SCHEMBL23283517 | 0.69 | METTL3 (0.62) | METTL3 | |
| SCHEMBL13192053 | 0.67 | ADORA2A (0.46) | EGFRSRCABL1KDR | |
| SCHEMBL15087029 | 0.65 | SRC (0.58) | EGFRSRCABL1KDR | |
| SCHEMBL2800044 | 0.64 | SRC (0.60) | EGFRSRCCDK1ABL1KDR | |
| SCHEMBL7833854 | 0.64 | SRC (0.86) | EGFRSRCCDK1ABL1KDR | |
| SCHEMBL7843429 | 0.64 | SRC (0.70) | EGFRSRCCDK1ABL1KDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021081211-A1 | METTL3 MODULATORS | ACCENT THERAPEUTICS, INC. (US) | 2021-04-29 | — | — | WO | disclosed |